New school program targets vaping and pill misuse in 7- to 11-year-olds
NCT ID NCT07162155
First seen Jun 25, 2026 · Last updated Jun 26, 2026 · Updated 1 time
Summary
This trial tests a school-based program that combines classroom lessons with online modules to reduce the risk of vaping and prescription drug misuse in upper elementary students (ages 7-11). About 3,000 students from 30 schools will either receive the program or continue with standard health education. Researchers will compare changes in behaviors, attitudes, and knowledge about vaping and prescription drugs over 12 months.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
School-based hybrid intervention (classroom sessions and e-learning modules)
What this could lead to
If it works, this program could provide an effective way to prevent vaping and prescription drug misuse in upper elementary students.
What could go wrong
This is an early-stage trial measuring attitudes and behaviors, not actual drug use. Results may not generalize to all schools or lead to long-term prevention.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for E-CIG USE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
National Health Promotion Associates
White Plains, New York, 10604, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••